MBody AI Ltd. (MBAI) vs Exagen Inc. (XGN)
MBody AI Ltd. and Exagen Inc. are both Diagnostics & Research companies. Exagen Inc. is the larger, with a market value of $233.3M against $69.0M — 3.4× the size. MBody AI Ltd. has the higher net margin (0.00% vs −26.6%) and the higher return on invested capital (0.00% vs −68.3%). Across the 14 metrics below, MBody AI Ltd. leads on 10 and Exagen Inc. on 4.
Valuation
Profitability
| Metric | MBAI | XGN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 0.00% | 58.64% | 50.89% |
| Operating margin | 0.00% | (18.58%) | (8.57%) |
| Net margin | 0.00% | (26.61%) | (6.37%) |
| Free cash flow margin | 0.00% | (10.66%) | 0.00% |
| Return on equity | 0.00% | (113.82%) | (2.92%) |
| Return on assets | 0.00% | (34.19%) | (6.71%) |
| Return on invested capital | 0.00% | (68.33%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack